Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Maria Dam Ferdinez

2PUBLICATIONS
41CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Jun 10, 2026
TNG917 is a Potent and Selective Inhibitor of Histone Lysine Methyltransferases EHMT1/2 that Enhances Anti-Tumor Immunity and Immunotherapy Efficacy.

|Sep 07, 2022
VRK1 Is a Synthetic-Lethal Target in VRK2-Deficient Glioblastoma.

Julie A Shields, Samuel R Meier, Madhavi Bandi

Pageof 1

Frequent Collaborators

2 joint publications

Alan Huang

2 joint publications

Yingnan Chen

2 joint publications

Wenhai Zhang

2 joint publications

Jannik N Andersen

2 joint publications

Minjie Zhang

1 joint publications

Samuel R Meier

1 joint publications

Madhavi Bandi

1 joint publications

Nicole Hajdari

1 joint publications

Justin L Engel

1 joint publications

Daniel J Silver

Frequent Collaborators

2 joint publications

Alan Huang

2 joint publications

Yingnan Chen

2 joint publications

Wenhai Zhang

2 joint publications

Jannik N Andersen